These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 25333900)

  • 1. Calcitonin controls bone formation by inhibiting the release of sphingosine 1-phosphate from osteoclasts.
    Keller J; Catala-Lehnen P; Huebner AK; Jeschke A; Heckt T; Lueth A; Krause M; Koehne T; Albers J; Schulze J; Schilling S; Haberland M; Denninger H; Neven M; Hermans-Borgmeyer I; Streichert T; Breer S; Barvencik F; Levkau B; Rathkolb B; Wolf E; Calzada-Wack J; Neff F; Gailus-Durner V; Fuchs H; de Angelis MH; Klutmann S; Tsourdi E; Hofbauer LC; Kleuser B; Chun J; Schinke T; Amling M
    Nat Commun; 2014 Oct; 5():5215. PubMed ID: 25333900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mice Lacking the Calcitonin Receptor Do Not Display Improved Bone Healing.
    Appelt J; Tsitsilonis S; Otto E; Jahn D; Köhli P; Baranowsky A; Jiang S; Fuchs M; Bucher CH; Duda GN; Frosch KH; Keller J
    Cells; 2021 Sep; 10(9):. PubMed ID: 34571953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation.
    Lotinun S; Kiviranta R; Matsubara T; Alzate JA; Neff L; Lüth A; Koskivirta I; Kleuser B; Vacher J; Vuorio E; Horne WC; Baron R
    J Clin Invest; 2013 Feb; 123(2):666-81. PubMed ID: 23321671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficiency of sphingosine-1-phosphate receptor 3 does not affect the skeletal phenotype of mice lacking sphingosine-1-phosphate lyase.
    Heckt T; Brylka LJ; Neven M; Amling M; Schinke T
    PLoS One; 2019; 14(7):e0219734. PubMed ID: 31314788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Species Effect: Differential Sphingosine-1-Phosphate Responses in the Bone in Human Versus Mouse.
    Frost K; Lewis JW; Jones SW; Edwards JR; Naylor AJ; McGettrick HM
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis.
    Ishii M; Egen JG; Klauschen F; Meier-Schellersheim M; Saeki Y; Vacher J; Proia RL; Germain RN
    Nature; 2009 Mar; 458(7237):524-8. PubMed ID: 19204730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of bone formation by osteoclasts involves Wnt/BMP signaling and the chemokine sphingosine-1-phosphate.
    Pederson L; Ruan M; Westendorf JJ; Khosla S; Oursler MJ
    Proc Natl Acad Sci U S A; 2008 Dec; 105(52):20764-9. PubMed ID: 19075223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sphingosine 1-phosphate (S1P) signalling: Role in bone biology and potential therapeutic target for bone repair.
    Sartawi Z; Schipani E; Ryan KB; Waeber C
    Pharmacol Res; 2017 Nov; 125(Pt B):232-245. PubMed ID: 28855094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sphingosine-1-phosphate signaling controlling osteoclasts and bone homeostasis.
    Ishii M; Kikuta J
    Biochim Biophys Acta; 2013 Jan; 1831(1):223-7. PubMed ID: 22691949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased S1P expression in osteoclasts enhances bone formation in an animal model of Paget's disease.
    Nagata Y; Miyagawa K; Ohata Y; Petrusca DN; Pagnotti GM; Mohammad KS; Guise TA; Windle JJ; David Roodman G; Kurihara N
    J Cell Biochem; 2021 Apr; 122(3-4):335-348. PubMed ID: 33107091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone: Key role for S1P in bone remodelling.
    Holmes D
    Nat Rev Endocrinol; 2015 Jan; 11(1):3. PubMed ID: 25350065
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemorepulsion by blood S1P regulates osteoclast precursor mobilization and bone remodeling in vivo.
    Ishii M; Kikuta J; Shimazu Y; Meier-Schellersheim M; Germain RN
    J Exp Med; 2010 Dec; 207(13):2793-8. PubMed ID: 21135136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoblast-derived sphingosine 1-phosphate to induce proliferation and confer resistance to therapeutics to bone metastasis-derived prostate cancer cells.
    Brizuela L; Martin C; Jeannot P; Ader I; Gstalder C; Andrieu G; Bocquet M; Laffosse JM; Gomez-Brouchet A; Malavaud B; Sabbadini RA; Cuvillier O
    Mol Oncol; 2014 Oct; 8(7):1181-95. PubMed ID: 24768038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sphingosine 1-phosphate signaling in bone remodeling: multifaceted roles and therapeutic potential.
    Meshcheryakova A; Mechtcheriakova D; Pietschmann P
    Expert Opin Ther Targets; 2017 Jul; 21(7):725-737. PubMed ID: 28524744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGF-β induces Wnt10b in osteoclasts from female mice to enhance coupling to osteoblasts.
    Ota K; Quint P; Ruan M; Pederson L; Westendorf JJ; Khosla S; Oursler MJ
    Endocrinology; 2013 Oct; 154(10):3745-52. PubMed ID: 23861379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of continuous calcitonin treatment on osteoclast-like cell development and calcitonin receptor expression in mouse bone marrow cultures.
    Ikegame M; Rakopoulos M; Martin TJ; Moseley JM; Findlay DM
    J Bone Miner Res; 1996 Apr; 11(4):456-65. PubMed ID: 8992876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MCP-1-induced human osteoclast-like cells are tartrate-resistant acid phosphatase, NFATc1, and calcitonin receptor-positive but require receptor activator of NFkappaB ligand for bone resorption.
    Kim MS; Day CJ; Selinger CI; Magno CL; Stephens SR; Morrison NA
    J Biol Chem; 2006 Jan; 281(2):1274-85. PubMed ID: 16280328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sphingosine-1-phosphate-mediated osteoclast precursor monocyte migration is a critical point of control in antibone-resorptive action of active vitamin D.
    Kikuta J; Kawamura S; Okiji F; Shirazaki M; Sakai S; Saito H; Ishii M
    Proc Natl Acad Sci U S A; 2013 Apr; 110(17):7009-13. PubMed ID: 23569273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sphingosine 1-phosphate as a regulator of osteoclast differentiation and osteoclast-osteoblast coupling.
    Ryu J; Kim HJ; Chang EJ; Huang H; Banno Y; Kim HH
    EMBO J; 2006 Dec; 25(24):5840-51. PubMed ID: 17124500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amylin inhibits bone resorption while the calcitonin receptor controls bone formation in vivo.
    Dacquin R; Davey RA; Laplace C; Levasseur R; Morris HA; Goldring SR; Gebre-Medhin S; Galson DL; Zajac JD; Karsenty G
    J Cell Biol; 2004 Feb; 164(4):509-14. PubMed ID: 14970190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.